Immunovant, Inc.IMVTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-422.89M
↓ 138% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-177.87M
Historical baseline
PeriodValueYoY Change
TTM$-422.89M-12.5%
2025$-375.87M-75.5%
2024$-214.23M-13.8%
2023$-188.19M-77.4%
2022$-106.11M-27.3%
2021$-83.33M-56.2%
2020$-53.36M-86.9%
2019$-28.55M+77.7%
2018$-128.30M-